ATE413882T1 - 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren - Google Patents

2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren

Info

Publication number
ATE413882T1
ATE413882T1 AT03751812T AT03751812T ATE413882T1 AT E413882 T1 ATE413882 T1 AT E413882T1 AT 03751812 T AT03751812 T AT 03751812T AT 03751812 T AT03751812 T AT 03751812T AT E413882 T1 ATE413882 T1 AT E413882T1
Authority
AT
Austria
Prior art keywords
sub
inhibitors
reuppose
phenylthiomethyl
morpholine derivatives
Prior art date
Application number
AT03751812T
Other languages
English (en)
Inventor
Magnus Wilhelm Walter
Barry Peter Clark
Peter Thaddeus Gallagher
Helen Louise Haughton
Helene C E Rudyk
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0219690A external-priority patent/GB0219690D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE413882T1 publication Critical patent/ATE413882T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03751812T 2002-08-23 2003-08-18 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren ATE413882T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219690A GB0219690D0 (en) 2002-08-23 2002-08-23 Benzyl morpholine derivatives
US41532802P 2002-10-01 2002-10-01

Publications (1)

Publication Number Publication Date
ATE413882T1 true ATE413882T1 (de) 2008-11-15

Family

ID=31948037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03751812T ATE413882T1 (de) 2002-08-23 2003-08-18 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren

Country Status (7)

Country Link
US (1) US7384941B2 (de)
EP (1) EP1534291B1 (de)
AT (1) ATE413882T1 (de)
AU (1) AU2003269923A1 (de)
DE (1) DE60324685D1 (de)
ES (1) ES2315525T3 (de)
WO (1) WO2004017977A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471943C (en) 2001-12-27 2011-09-20 Daiichi Pharmaceutical Co., Ltd. .beta.-amyloid protein production-secretion inhibitors
WO2004018440A1 (en) 2002-08-23 2004-03-04 Eli Lilly And Company Benzyl morpholine derivatives
GB0219687D0 (en) * 2002-08-23 2002-10-02 Lilly Co Eli Benzyl morpholine derivatives
KR20060066057A (ko) 2003-06-30 2006-06-15 다이이찌 세이야꾸 가부시기가이샤 복소환 메틸 설폰 유도체
GB0319793D0 (en) 2003-08-22 2003-09-24 Lilly Co Eli Pyridinylmorpholine derivatives
DE602004014823D1 (de) * 2003-12-12 2008-08-14 Lilly Co Eli Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen
DE602004019698D1 (de) 2003-12-23 2009-04-09 Lilly Co Eli Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
KR100943555B1 (ko) * 2004-04-30 2010-02-22 워너-램버트 캄파니 엘엘씨 중추신경계 장애를 치료하기 위한 치환된 모르폴린 화합물
WO2007005935A2 (en) * 2005-07-06 2007-01-11 Molecular Neuroimaging, Llc Norepinephrine transporter radiotracers and methods of syntheses thereof
TWI438190B (zh) * 2008-07-24 2014-05-21 Theravance Inc 3-(苯氧基苯基甲基)吡咯啶化合物
HRP20120920T1 (hr) 2008-11-14 2013-01-31 Theravance, Inc. Spojevi 4-[2-(2 fluorofenoksimetil)fenil]piperidina
JP2012524098A (ja) * 2009-04-15 2012-10-11 セラヴァンス, インコーポレーテッド 3−(フェノキシピロリジン−3−イル−メチル)ヘテロアリール、3−(フェニルピロリジン−3−イルメトキシ)ヘテロアリールおよび3−(ヘテロアリールピロリジン−3−イルメトキシ)ヘテロアリール化合物
AU2010273645B2 (en) * 2009-07-13 2014-12-04 Theravance Biopharma R&D Ip, Llc 3-phenoxymethylpyrrolidine compounds
ES2495366T3 (es) 2009-07-21 2014-09-17 Theravance, Inc. Compuestos de 3-fenoximetilpirrolidina
EP2523945A1 (de) 2010-01-11 2012-11-21 Theravance, Inc. 1-(2-phenoxymethylphenyl-)piperazinverbindungen als serotonin- und norepinephrin-wiederaufnahmehemmer
ES2543064T3 (es) * 2010-03-22 2015-08-14 Theravance Biopharma R&D Ip, Llc Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina
EP2627630B1 (de) 2010-10-11 2014-12-31 Theravance Biopharma R&D IP, LLC Serotonin-wiederaufnahmehemmer
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759013R (fr) 1969-11-17 1971-05-17 Ici Ltd Derives de la
GB1412546A (en) 1973-08-08 1975-11-05 Ici Ltd Morpholine derivatives
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
US5658590A (en) 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
AU709704B2 (en) 1995-07-24 1999-09-02 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
JP2001517628A (ja) 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー 注意欠陥/多動障害の治療法
ATE365042T1 (de) 1998-01-21 2007-07-15 Glaxo Group Ltd Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
GB9812662D0 (en) 1998-06-11 1998-08-12 Merck Sharp & Dohme Therapeutic use
US6503905B1 (en) 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
IL144309A0 (en) 1999-02-23 2002-05-23 Pfizer Prod Inc Monoamine reuptake inhibitors for treatment of cns disorders
ATE304358T1 (de) 1999-07-01 2005-09-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von migränekopfschmerzen

Also Published As

Publication number Publication date
US20060035894A1 (en) 2006-02-16
EP1534291B1 (de) 2008-11-12
US7384941B2 (en) 2008-06-10
WO2004017977A2 (en) 2004-03-04
AU2003269923A1 (en) 2004-03-11
EP1534291A2 (de) 2005-06-01
DE60324685D1 (de) 2008-12-24
ES2315525T3 (es) 2009-04-01
WO2004017977A3 (en) 2004-04-01
AU2003269923A8 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
BRPI0413232A (pt) novos compostos tendo atividade inibitória contra os trasnportadores dependentes de sódio
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
EP1642880A4 (de) Proteininhibitoren der hsp90-familie
EP1104764A4 (de) 1h-imidazopyridin-derivate
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DE60317198D1 (de) Proteinkinaseinhibitoren
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
FI821733A0 (fi) Blodtryckssaenkande 1-substituerade spiropiperidinoxobenzoxazin/t
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
ATE343566T1 (de) Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren
EA200200523A1 (ru) Новые разветвленные замещенные аминопроизводные 3-амино-1-фенил-1h[1,2,4]триазола, способы их получения и содержащие их фармацевтические композиции
DK1628968T3 (da) 4-imidazolin-2-on-forbindelser
EA200800149A1 (ru) 4,5-диарилпиррольные производные, способ их получения и применение в терапии
EA200101050A1 (ru) Замещенные бензолактамные соединения
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
UA89619C2 (ru) Соединения пиперазина, способ их получения и фармацевтическая композиция, которая их содержит
ATE327982T1 (de) Benzylmorpholinderivate
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties